Danaher Continues Life Sciences Business Expansion with US$9.6 B Aldevron Acquisition

By Debadrita Paul

Pharma Deals Review: Vol 2021 Issue 7 (Table of Contents)

Published: 23 Jul-2021

DOI: 10.3833/pdr.v2021.i7.2627     ISSN: 1756-7874

Section: Mergers & Acquisitions



Danaher has agreed to acquire Aldevron, a manufacturer of plasmid DNA, mRNA, and recombinant proteins for projects ranging from early-stage research to clinical trials and commercial applications...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details